-- Preview Email Newsletter
| Newsletter for ( 2 items ) |
|
Anheuser-Busch Announces New $300 Million Investment in Manufacturing Operations Across the U.S. (10)
ST. LOUIS, Missouri, May 13 -- Anheuser-Busch, a brewing company, issued the following news release:
* * *
Anheuser-Busch Announces New $300 Million Investment in Manufacturing Operations Across the U.S.
Leading American manufacturer builds on longstanding commitment to creating jobs and driving economic prosperity through expanded investment in its breweries, technical skills training, and support for hiring veterans
St. Louis, MO - May 12, 2025 - Today, Anheuser-Busch (NYSE: BUD), a lead more PR
Washington University School of Medicine: Drug to Slow Alzheimer's Well Tolerated Outside of Clinical Trial Setting (10)
ST. LOUIS, Missouri, May 13 -- The Washington University School of Medicine issued the following news release:
* * *
Drug to slow Alzheimer's well tolerated outside of clinical trial setting
Side effects of lecanemab are manageable, study finds
In a recent study, researchers at WashU Medicine found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions at the Memory Diagnostic Center at WashU Medicine.
The Fo more PR
|
